Amalgamated Bank’s Albireo Pharma Inc ALBO Stock Holding History

Amalgamated Bank’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,741	Closed	-$59K	–	2958
2022 Q4	$59K	Hold	2,741	–	–	﹤0.01%	2353
2022 Q3	$53K	Buy	2,741 +41	+2%	+$848	﹤0.01%	2437
2022 Q2	$54K	Buy	2,700 +98	+4%	+$2.58K	﹤0.01%	2442
2022 Q1	$78K	Buy	+2,602	New	+$76.2K	﹤0.01%	2295

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Amalgamated Bank's ALBO Position: Q1 2023 in Review

Amalgamated Bank sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 2,741 shares — an estimated $59K sold.

Amalgamated Bank first reported a position in ALBO in Q1 2022 and held it in 4 quarters. The position peaked at $78K in Q1 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Amalgamated Bank reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Amalgamated Bank sold 2,741 Albireo Pharma Inc shares in Q1 2023, an estimated $59K.
Amalgamated Bank first reported a position in Albireo Pharma Inc in Q1 2022 and held it in 4 quarters.
Amalgamated Bank's Albireo Pharma Inc position peaked at $78K in Q1 2022.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Amalgamated Bank's 13F filing for Q1 2023, filed 2 May 2023.